Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Telesis Bio provides an end-to-end synthetic biology platform (BioXp) and Gibson SOLA-based workflows for on-site DNA and RNA synthesis, cloning, and library preparation, enabling researchers to run workflows in their own labs. Its solutions accelerate therapeutic discovery across antibody drug discovery, cell and gene therapy, and vaccine development by enabling real-time iteration and reducing outsourcing delays. The company emphasizes control over build timelines and IP, with workflows designed to cut time to results and increase fidelity, speed, and throughput.
Parse Score